Literature DB >> 1512352

Low energy conversion of atrial fibrillation in the sheep.

A C Powell1, H Garan, B A McGovern, J T Fallon, S C Krishnan, J N Ruskin.   

Abstract

OBJECTIVES: In this study, the feasibility, efficacy and safety of low energy internal atrial cardioversion were investigated in a sheep model. The relation between the level of energy used for atrial defibrillation and the probability of successful cardioversion was examined.
BACKGROUND: Atrial fibrillation is a common clinical arrhythmia that frequently recurs after termination with high energy external cardioversion. In some patients with drug-refractory and poorly tolerated atrial fibrillation, an automatic implantable cardioverter may prove useful by providing rapid restoration of sinus rhythm.
METHODS: In 16 pentobarbital-anesthetized sheep, a right atrial spring electrode was implanted percutaneously and a left thoracic cutaneous patch electrode was placed on the thorax. Sustained atrial fibrillation was induced by rapid atrial pacing and terminated by biphasic cathodal shocks synchronized to the R wave of the surface electrocardiogram (ECG).
RESULTS: During 768 defibrillation attempts in 16 sheep, the percent of successful cardioversion attempts increased in a dose-response manner, reaching a plateau at the average energy level of 5 J. With greater than or equal to 1.5 and greater than or equal to 2.5 J energy levels, cardioversion was achieved, respectively, in greater than 50% and greater than 80% of attempts. Ventricular fibrillation occurred in 18 (2.4%) of 768 cardioversion attempts; in all 18 cases, the shock was poorly synchronized with the ECG R wave.
CONCLUSIONS: Low energy cardioversion of atrial fibrillation to sinus rhythm is feasible with use of a right atrial spring/cutaneous patch electrode configuration. The percent of successful cardioversion attempts depends on the level of energy output, and there is a risk of ventricular fibrillation if cardioversion is poorly synchronized with ventricular depolarization.

Entities:  

Mesh:

Year:  1992        PMID: 1512352     DOI: 10.1016/0735-1097(92)90028-l

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  8 in total

Review 1.  [Cardiology update. I: Electrophysiology].

Authors:  P Weismüller; H J Trappe
Journal:  Med Klin (Munich)       Date:  1999-01-15

2.  Pharmacologic enhancement of atrial electrical defibrillation efficacy: role of ibutilide.

Authors:  D S Khoury; M D Assar; H Sun
Journal:  J Interv Card Electrophysiol       Date:  1997-12       Impact factor: 1.900

Review 3.  Low-energy internal cardioversion of atrial fibrillation after failed external cardioversion: Texas Heart Institute experience and review of the literature.

Authors:  M Zaqqa; H Afshar; G R Khoshnevis; J A Lopez; A Massumi
Journal:  Tex Heart Inst J       Date:  1999

4.  Efficacy of a new balloon catheter for internal cardioversion of chronic atrial fibrillation without anaesthesia.

Authors:  E Alt; R Ammer; G Lehmann; C Schmitt; J Pasquantonio; A Schömig
Journal:  Heart       Date:  1998-02       Impact factor: 5.994

Review 5.  Maintaining stability of sinus rhythm in atrial fibrillation: antiarrhythmic drugs versus ablation.

Authors:  Gerald V Naccarelli; John Hynes; Deborah L Wolbrette; Luna Bhatta; Mazhar Khan; Jerry Luck
Journal:  Curr Cardiol Rep       Date:  2002-09       Impact factor: 2.931

6.  Minimum energy single-shock internal atrial defibrillation in sheep.

Authors:  Amy M Goodman; Merlise A Clyde; Donald S Burdick; Salim F Idriss; Patrick D Wolf
Journal:  J Interv Card Electrophysiol       Date:  2004-04       Impact factor: 1.900

Review 7.  The treatment of atrial fibrillation. An evaluation of drug therapy, electrical modalities and therapeutic considerations.

Authors:  S Nattel; T Hadjis; M Talajic
Journal:  Drugs       Date:  1994-09       Impact factor: 9.546

8.  Current status of internal cardioversion in atrial fibrillation.

Authors:  Andreas Plewan; Eckhard Alt
Journal:  Indian Pacing Electrophysiol J       Date:  2002-04-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.